This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (170)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Mark F. Prummel, MD, PhD; Wilmar M. Wiersinga, MD, PhD

JAMA. 1993;269(4):479-482.

Abstract
Objective.
—To assess if smoking is associated with Graves' disease and, if so, to ascertain whether this association persists when controlling for confounding factors.

Design.
—Consecutive entry case-control study with two age- and sex-matched control subjects from two different populations per case patient.

Setting.
—University hospital.

Patients.
—Five groups were studied: (1) Graves' ophthalmopathy and Graves' hyperthyroidism (n=100; divided in four subgroups according to the severity of the eye disease); (2) Graves' hyperthyroidism without clinical eye involvement (n=100); (3) sporadic nontoxic goiter (n=100); (4) autoimmune hypothyroidism (n=75); and (5) toxic nodular goiter (n=75). The study comprised 200 subjects from a hospitalbased population, and 200 from a population-based group served as control subjects.

Main Outcome Measure.
—Smoking status was determined from a questionnaire at the time of onset of the disease to exclude any effect of the disease itself on smoking.

Results.
—Smoking greatly increased the risk for Graves' ophthalmopathy (odds ratio, 7.7; 95% confidence interval, 4.3 to 13.7), but patients with Graves' hyperthyroidism alone were also more often smokers than control subjects (odds ratio, 1.9; 95% confidence interval, 1.1 to 3.2). Smoking was not associated with the other thyroid diseases studied. Essentially similar results were obtained after adjustment for differences in education between case patients and control subjects. Among the patients with Graves' ophthalmopathy, smokers had more severe eye disease than nonsmokers, but no association was found between the number of cigarettes smoked per day or the duration of smoking and the severity of the ophthalmopathy. However, there was a significant increase in the odds ratios in patients with more severe eye disease.

Conclusions.
—Smoking is associated with Graves' disease, and it especially increases the risk for the development of more severe ophthalmopathy. Thus, smoking appears to be one of the multiple factors inducing Graves' disease in genetically predisposed individuals.

(JAMA. 1993;269:479-482)

Author Affiliations
From the Department of Endocrinology, Academic Medical Centre, University of Amsterdam (the Netherlands). Dr Prummel is now at the Thyroid Molecular Biology Laboratory, Veterans Administration Medical Center, San Francisco, Calif.

Footnotes
Presented, in part, at the 10th International Thyroid Conference, The Hague, the Netherlands, February 3, 1991.

Reprint requests to Department of Endocrinology, F5-258, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands (Dr Prummel).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment Modalities for Graves' Ophthalmopathy: Systematic Review and Metaanalysis
Stiebel-Kalish et al.
J. Clin. Endocrinol. Metab. 2009;94:2708-2716.
ABSTRACT | FULL TEXT  

Variation in phenotypic appearance of Graves' disease: effect of genetic anticipation and duration of complaints
Vos et al.
Eur J Endocrinol 2009;161:113-118.
ABSTRACT | FULL TEXT  

Discontinuation of Smoking Increases the Risk for Developing Thyroid Peroxidase Antibodies and/or Thyroglobulin Antibodies: A Prospective Study
Effraimidis et al.
J. Clin. Endocrinol. Metab. 2009;94:1324-1328.
ABSTRACT | FULL TEXT  

Thyroid-Stimulating Hormone-Receptor Antibody and Thyroid Hormone Concentrations in Smokers vs Nonsmokers With Graves Disease Treated With Carbimazole
Nyirenda et al.
JAMA 2009;301:162-164.
FULL TEXT  

Environmental tobacco smoke exposure and eye disease
Lois et al.
Br J Ophthalmol 2008;92:1304-1310.
ABSTRACT | FULL TEXT  

Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations
Koskenmies et al.
Lupus 2008;17:337-347.
ABSTRACT  

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Bartalena et al.
Eur J Endocrinol 2008;158:273-285.
FULL TEXT  

Tobacco Smoking and Thyroid Function: A Population-Based Study
Asvold et al.
Arch Intern Med 2007;167:1428-1432.
ABSTRACT | FULL TEXT  

Smoking and Thyroid-Associated Ophthalmopathy: A Novel Explanation of the Biological Link
Cawood et al.
J. Clin. Endocrinol. Metab. 2007;92:59-64.
ABSTRACT | FULL TEXT  

Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype
Manji et al.
J. Clin. Endocrinol. Metab. 2006;91:4873-4880.
ABSTRACT | FULL TEXT  

Is Alveolar Destruction and Emphysema in Chronic Obstructive Pulmonary Disease an Immune Disease?
Taraseviciene-Stewart et al.
Proc Am Thorac Soc 2006;3:687-690.
ABSTRACT | FULL TEXT  

Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Costenbader and Karlson
Lupus 2006;15:737-745.
ABSTRACT  

Altered Tear Composition in Smokers and Patients With Graves Ophthalmopathy
Baker et al.
Arch Ophthalmol 2006;124:1451-1456.
ABSTRACT | FULL TEXT  

Smoking and autoimmune thyroid disease: the plot thickens.
Krassas and Wiersinga
Eur J Endocrinol 2006;154:777-780.
ABSTRACT | FULL TEXT  

Childhood Graves' ophthalmopathy: results of a European questionnaire study
Krassas et al.
Eur J Endocrinol 2005;153:515-521.
ABSTRACT | FULL TEXT  

Effect of Cigarette Smoke on Autoimmunity in Murine and Human Systemic Lupus Erythematosus
Rubin et al.
Toxicol Sci 2005;87:86-96.
ABSTRACT | FULL TEXT  

Smoking and Other Lifestyle Factors and the Risk of Graves' Hyperthyroidism
Holm et al.
Arch Intern Med 2005;165:1606-1611.
ABSTRACT | FULL TEXT  

Smoking and hormones in health and endocrine disorders
Kapoor and Jones
Eur J Endocrinol 2005;152:491-499.
ABSTRACT | FULL TEXT  

Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves' Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study
Wemeau et al.
J. Clin. Endocrinol. Metab. 2005;90:841-848.
ABSTRACT | FULL TEXT  

Smoke Exposure Is Associated with a Lower Prevalence of Serum Thyroid Autoantibodies and Thyrotropin Concentration Elevation and a Higher Prevalence of Mild Thyrotropin Concentration Suppression in the Third National Health and Nutrition Examination Survey (NHANES III)
Belin et al.
J. Clin. Endocrinol. Metab. 2004;89:6077-6086.
ABSTRACT | FULL TEXT  

Preventing Visual Loss From Chronic Eye Disease in Primary Care: Scientific Review
Rowe et al.
JAMA 2004;291:1487-1495.
ABSTRACT | FULL TEXT  

Current Perspective on the Pathogenesis of Graves' Disease and Ophthalmopathy
Prabhakar et al.
Endocr. Rev. 2003;24:802-835.
ABSTRACT | FULL TEXT  

Impact of smoking on the response to treatment of thyroid associated ophthalmopathy
Eckstein et al.
Br J Ophthalmol 2003;87:773-776.
ABSTRACT | FULL TEXT  

Pathophysiology of Graves' Ophthalmopathy: The Cycle of Disease
Bahn
J. Clin. Endocrinol. Metab. 2003;88:1939-1946.
FULL TEXT  

In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis
Bridger et al.
Gut 2002;51:21-25.
ABSTRACT | FULL TEXT  

Does radiotherapy have a role in the management of thyroid orbitopathy?
McNab et al.
Br J Ophthalmol 2002;86:102-107.
FULL TEXT  

Postpartum Thyroiditis and Autoimmune Thyroiditis in Women of Childbearing Age: Recent Insights and Consequences for Antenatal and Postnatal Care
Muller et al.
Endocr. Rev. 2001;22:605-630.
ABSTRACT | FULL TEXT  

Cigarette Smoking and Incidence of Multiple Sclerosis
Hernan et al.
Am J Epidemiol 2001;154:69-74.
ABSTRACT | FULL TEXT  

Pathogenesis of Graves' Ophthalmopathy--Current Understanding
Wiersinga and Prummel
J. Clin. Endocrinol. Metab. 2001;86:501-503.
FULL TEXT  

Management of Graves' Ophthalmopathy: Reality and Perspectives
Bartalena et al.
Endocr. Rev. 2000;21:168-199.
ABSTRACT | FULL TEXT  

Thyroid eye disease associated with athyria
ROGERS et al.
Br J Ophthalmol 2000;84:439-439.
FULL TEXT  

Cigarette Smoking and Risk of Clinically Overt Thyroid Disease: A Population-Based Twin Case-Control Study
Brix et al.
Arch Intern Med 2000;160:661-666.
ABSTRACT | FULL TEXT  

Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy
Hosal et al.
Br J Ophthalmol 1999;83:605-608.
ABSTRACT | FULL TEXT  

Diabetes mellitus: a risk factor in patients with Graves' orbitopathy
Kalmann and Mourits
Br J Ophthalmol 1999;83:463-465.
ABSTRACT | FULL TEXT  

Is Graves Ophthalmopathy a Preventable Disease?
Keltner
Arch Ophthalmol 1998;116:1106-1107.
FULL TEXT  

Preventing Graves' Ophthalmopathy
Wiersinga
NEJM 1998;338:121-122.
FULL TEXT  

Soluble Interleukin-1 Receptor Antagonist Serum Levels in Smokers and Nonsmokers with Graves' Ophthalmopathy Undergoing Orbital Radiotherapy
Hofbauer et al.
J. Clin. Endocrinol. Metab. 1997;82:2244-2247.
ABSTRACT | FULL TEXT  

Cigarette Smoking and the Thyroid
Utiger
NEJM 1995;333:1001-1002.
FULL TEXT  

Pathogenesis of Graves' Ophthalmopathy
Bahn and Heufelder
NEJM 1993;329:1468-1475.
FULL TEXT  

SMOKING IS LINKED TO GRAVES' DISEASE
JWatch General 1993;1993:1-1.
FULL TEXT  

Tobacco and Graves' Disease: Smoking Gun or Smoke and Mirrors?
Cooper
JAMA 1993;269:518-519.
ABSTRACT